FDA Inspection 666605 — Sanofi Aventis Recherche & Developpement
The FDA completed an inspection of Sanofi Aventis Recherche & Developpement on Apr 30, 2010 in Vitry Sur Seine Cedex. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 30, 2010
- Fiscal Year
- 2010
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Vitry Sur Seine Cedex (France)